SCHEDULE: FMR LLC Reports 10.4% Stake in ARCELLX INC
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson disclose a 10.4% beneficial ownership stake in ARCELLX INC, holding over 5.7 million shares of common stock.
Summary
- FMR LLC and Abigail P. Johnson are reporting beneficial ownership of ARCELLX INC common stock.
- The aggregate amount beneficially owned by FMR LLC and Abigail P. Johnson is 5,761,317.46 shares.
- This ownership represents 10.4% of ARCELLX INC's class of common stock.
- FMR LLC holds sole voting power over 5,759,535.00 shares and sole dispositive power over 5,761,317.46 shares.
- Abigail P. Johnson holds sole dispositive power over 5,761,317.46 shares.
- The filing is an Amendment No. 5 to a previous Schedule 13G.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of ARCELLX INC.
Sentiment
Score: 7
Explanation: The disclosure of a significant 10.4% beneficial ownership stake by a prominent institutional investor like FMR LLC can be interpreted as a positive signal of confidence in ARCELLX INC's long-term prospects and stability.
Positives
- A significant 10.4% beneficial ownership by a major institutional investor like FMR LLC can signal confidence in ARCELLX INC's prospects.
- The filing indicates continued institutional interest in ARCELLX INC's common stock.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from ARCELLX INC.
Industry Context
FMR LLC is a prominent global asset management firm. Their significant stake in ARCELLX INC, a biotechnology company, highlights institutional investment interest in the life sciences sector, potentially driven by specific developments or long-term growth prospects within the industry.
Stakeholder Impact
- Shareholders benefit from increased transparency regarding significant institutional holdings, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC and its direct and indirect subsidiaries. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC (referenced for Power of Attorney). |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC (referenced for Power of Attorney). |
| 2025-09-30 | Date of event which requires filing of this statement. |
| 2025-11-04 | Signature date of the Schedule 13G filing. |
Keywords
ARCELLX INC, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, institutional investor, common stock, biotechnology, asset management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.